Adial Pharmaceuticals (ADIL) holder Coastlands Capital adds 25,000 shares

Rhea-AI Filing Summary

Adial Pharmaceuticals major holder Coastlands Capital LP reported an open-market purchase of common stock. On this transaction date, an entity associated with Coastlands bought 25,000 Adial shares at $2.60 each, increasing its indirectly held position to 373,322 shares. The filing notes that Coastlands and related entities disclaim beneficial ownership beyond their pecuniary interest in these holdings.

Insider Trade Summary

Net Buyer: 25,000 shares ($65,000)

Net Buy 1 txn

Insider Coastlands Capital LP

Role null

Bought 25,000 shs ($65K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	25,000	$2.60	$65K

Holdings After Transaction: Common Stock — 373,322 shares (Indirect, By Coastlands Capital LP)

Footnotes (1)

1. [object Object]

Key Figures

Shares purchased: 25,000 shares Purchase price: $2.60 per share Shares owned after: 373,322 shares +4 more

7 metrics

Shares purchased 25,000 shares Open-market purchase of Adial common stock

Purchase price $2.60 per share Price paid in the open-market transaction

Shares owned after 373,322 shares Indirect holdings following the transaction

Net buy shares 25,000 shares Net change in position from this Form 4

Buy transactions 1 transaction Count of purchase transactions reported

Ownership type Indirect Held through Coastlands Capital Partners LP

Insider status Ten percent owner Coastlands Capital LP classification

Key Terms

open-market purchase, indirect ownership, ten percent owner, pecuniary interest, +1 more

5 terms

open-market purchase financial

"transaction_action: open-market purchase"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

indirect ownership financial

"ownership_type: indirect; nature_of_ownership: By Coastlands Capital LP"

ten percent owner financial

"is_ten_percent_owner: 1"

pecuniary interest financial

"disclaims beneficial ownership of common stock except to the extent of that person's pecuniary interest"

beneficial ownership financial

"each reporting person also disclaims beneficial ownership of common stock"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/01/2026 - 10:30 AM Accepted by SEC EDGAR 07/01/2026 - 10:30 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Coastlands Capital LP

(Last) (First) (Middle)

601 CALIFORNIA STREET

SUITE 1210

(Street)

SAN FRANCISCO CALIFORNIA 94108

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ADIAL PHARMACEUTICALS, INC. [ ADIL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/29/2026		P		25,000	A	$2.6	373,322	I	By Coastlands Capital LP(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Coastlands Capital LP ("Coastlands") and Coastlands Capital GP LLC (the "General Partner") are the investment adviser and general partner, respectively, of Coastlands Capital Partners LP, a Delaware limited partnership (the "Partnership"). Coastlands Capital LLC ("Coastlands GP") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person's pecuniary interest therein.

	/s/ Mark Shamia, Chief Operating Officer of the General Partner of Coastlands Capital LP	07/01/2026
	/s/ Mark Shamia, Chief Operating Officer of the General Partner of Coastlands Capital Partners LP	07/01/2026
	/s/ Mark Shamia, Chief Operating Officer of Coastlands Capital GP LLC	07/01/2026
	/s/ Mark Shamia, Chief Operating Officer of Coastlands Capital LLC	07/01/2026
	/s/ Matthew D. Perry	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Coastlands Capital report for ADIL?

Coastlands Capital LP reported an open-market purchase of ADIL shares. An affiliated entity bought 25,000 shares of Adial Pharmaceuticals common stock at $2.60 per share, increasing the indirect position to 373,322 shares following the transaction.

At what price were the ADIL shares purchased by Coastlands Capital?

The ADIL shares were purchased at $2.60 per share. Coastlands Capital LP reported an open-market transaction for 25,000 shares of Adial Pharmaceuticals common stock at this price, as disclosed in the Form 4 insider trading report.

How many ADIL shares does Coastlands Capital hold after this Form 4 transaction?

After the transaction, Coastlands’ affiliated entity holds 373,322 ADIL shares. The Form 4 shows this as the total indirect ownership in Adial Pharmaceuticals common stock following the 25,000-share open-market purchase.

Is Coastlands Capital considered a ten percent owner of ADIL?

Yes, Coastlands Capital is identified as a ten percent owner. The Form 4 indicates Coastlands Capital LP is a ten percent owner of Adial Pharmaceuticals and reports its holdings as indirect, through a partnership structure.

How is Coastlands Capital’s ownership in ADIL characterized in the filing?

The ownership is reported as indirect through a partnership vehicle. Shares are held by Coastlands Capital Partners LP, with related general partners and entities, and each reporting person disclaims beneficial ownership beyond their pecuniary interest.